Connection

Allen Kaplan to Bradykinin

This is a "connection" page, showing publications Allen Kaplan has written about Bradykinin.
Connection Strength

9.094
  1. Pathways for bradykinin formation and interrelationship with complement as a cause of edematous lung in COVID-19 patients. J Allergy Clin Immunol. 2021 Feb; 147(2):507-509.
    View in: PubMed
    Score: 0.654
  2. Preventing anaphylaxis fatalities: Should we target bradykinin? J Allergy Clin Immunol. 2020 05; 145(5):1365-1366.
    View in: PubMed
    Score: 0.622
  3. Fibrinolysis and bradykinin formation: From in?vitro observations to human disease in "just" 45?years. J Allergy Clin Immunol. 2016 11; 138(5):1424-1425.
    View in: PubMed
    Score: 0.488
  4. A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes. Allergy. 2015 Jan; 70(1):115-9.
    View in: PubMed
    Score: 0.430
  5. Bradykinin-mediated diseases. Chem Immunol Allergy. 2014; 100:140-7.
    View in: PubMed
    Score: 0.418
  6. The bradykinin-forming cascade: a historical perspective. Chem Immunol Allergy. 2014; 100:205-13.
    View in: PubMed
    Score: 0.418
  7. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway. Adv Immunol. 2014; 121:41-89.
    View in: PubMed
    Score: 0.407
  8. In vitro comparison of bradykinin degradation by aliskiren, a renin inhibitor, and an inhibitor of angiotensin-converting enzyme. J Renin Angiotensin Aldosterone Syst. 2015 Jun; 16(2):321-7.
    View in: PubMed
    Score: 0.392
  9. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II. J Allergy Clin Immunol. 2013 Aug; 132(2):470-5.
    View in: PubMed
    Score: 0.390
  10. The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol. 2010 Aug; 47(13):2161-9.
    View in: PubMed
    Score: 0.321
  11. Kinin formation in C1 inhibitor deficiency. J Allergy Clin Immunol. 2010 Jun; 125(6):1411-2; author reply 1412.
    View in: PubMed
    Score: 0.314
  12. The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol. 2010 Mar; 104(3):193-204.
    View in: PubMed
    Score: 0.312
  13. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis. Ann Allergy Asthma Immunol. 2010 Jan; 104(1):50-4.
    View in: PubMed
    Score: 0.309
  14. Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol. 2008 Sep; 101(3):279-86.
    View in: PubMed
    Score: 0.281
  15. Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol. 2005; 86:159-208.
    View in: PubMed
    Score: 0.218
  16. Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90. Int Immunopharmacol. 2002 Dec; 2(13-14):1851-9.
    View in: PubMed
    Score: 0.189
  17. Bradykinin formation by mutant plasminogen. Blood. 2022 05 05; 139(18):2732-2733.
    View in: PubMed
    Score: 0.181
  18. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade. J Allergy Clin Immunol Pract. 2022 03; 10(3):716-722.
    View in: PubMed
    Score: 0.176
  19. gC1qR Antibody Can Modulate Endothelial Cell Permeability in Angioedema. Inflammation. 2022 Feb; 45(1):116-128.
    View in: PubMed
    Score: 0.173
  20. Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema. Clin Rev Allergy Immunol. 2021 Jun; 60(3):348-356.
    View in: PubMed
    Score: 0.169
  21. Hereditary angioedema: Investigational therapies and future research. Allergy Asthma Proc. 2020 11 01; 41(Suppl 1):S51-S54.
    View in: PubMed
    Score: 0.164
  22. Protease activity in single-chain prekallikrein. Blood. 2020 02 20; 135(8):558-567.
    View in: PubMed
    Score: 0.156
  23. Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin-Forming Cascade. Immunol Allergy Clin North Am. 2017 08; 37(3):513-525.
    View in: PubMed
    Score: 0.131
  24. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent. Clin Rev Allergy Immunol. 2016 Oct; 51(2):207-15.
    View in: PubMed
    Score: 0.123
  25. Bradykinin levels during experimental nasal infection with rhinovirus and attenuated influenza virus. Immunopharmacology. 1996 Jun; 33(1-3):311-3.
    View in: PubMed
    Score: 0.120
  26. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels. J Allergy Clin Immunol. 2016 06; 137(6):1822-1829.e1.
    View in: PubMed
    Score: 0.115
  27. Assembly of the human plasma kinin-forming cascade along the surface of vascular endothelial cells. Int Arch Allergy Immunol. 1995 May-Jun; 107(1-3):93-4.
    View in: PubMed
    Score: 0.112
  28. Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23-24 August 2012. Inflamm Res. 2014 Mar; 63(3):173-8.
    View in: PubMed
    Score: 0.101
  29. Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS One. 2013; 8(2):e53773.
    View in: PubMed
    Score: 0.096
  30. Effect of Neurotropin on the activation of the plasma kallikrein-kinin system. Biochem Pharmacol. 1992 Mar 17; 43(6):1361-9.
    View in: PubMed
    Score: 0.090
  31. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor. J Allergy Clin Immunol. 2009 Jul; 124(1):143-9.
    View in: PubMed
    Score: 0.073
  32. Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products. Biochem Pharmacol. 1989 Mar 15; 38(6):993-1000.
    View in: PubMed
    Score: 0.073
  33. Relationship of Hageman factor activation to the formation of bradykinin in humans: a historical perspective. Prog Clin Biol Res. 1989; 297:311-23.
    View in: PubMed
    Score: 0.072
  34. Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme. Biochem Pharmacol. 1986 Jun 15; 35(12):1951-6.
    View in: PubMed
    Score: 0.060
  35. Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N. Biochem Pharmacol. 1986 Jun 15; 35(12):1957-63.
    View in: PubMed
    Score: 0.060
  36. Assembly, activation, and signaling by kinin-forming proteins on human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2005 Jul; 289(1):H251-7.
    View in: PubMed
    Score: 0.056
  37. Assessment of histamine release and kinin formation in man: identification of kinin degradation products and characterization of a lymphocyte-dependent histamine releasing factor. Int Arch Allergy Appl Immunol. 1985; 77(1-2):64-8.
    View in: PubMed
    Score: 0.055
  38. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation. Fed Proc. 1983 Nov; 42(14):3123-7.
    View in: PubMed
    Score: 0.050
  39. Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin. J Allergy Clin Immunol. 1983 Jul; 72(1):54-60.
    View in: PubMed
    Score: 0.049
  40. Mechanisms of bradykinin generation in human plasma. Monogr Allergy. 1983; 18:272-6.
    View in: PubMed
    Score: 0.047
  41. Analysis of cold activation of the contact system in hereditary angioedema with normal C1 inhibitor. Mol Immunol. 2021 08; 136:150-160.
    View in: PubMed
    Score: 0.043
  42. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease. Immunopharmacology. 1999 Sep; 43(2-3):203-10.
    View in: PubMed
    Score: 0.038
  43. Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein. Clin Immunol. 1999 Jan; 90(1):89-99.
    View in: PubMed
    Score: 0.036
  44. Effect of neurotropin on the binding of high molecular weight kininogen and Hageman factor to human umbilical vein endothelial cells and the autoactivation of bound Hageman factor. Biochem Pharmacol. 1998 Apr 15; 55(8):1175-80.
    View in: PubMed
    Score: 0.034
  45. Bradykinin formation. Plasma and tissue pathways and cellular interactions. Clin Rev Allergy Immunol. 1998; 16(4):403-29.
    View in: PubMed
    Score: 0.034
  46. The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis. Monogr Allergy. 1977; 12:120-30.
    View in: PubMed
    Score: 0.031
  47. The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation. Adv Immunol. 1997; 66:225-72.
    View in: PubMed
    Score: 0.031
  48. Bradykinin generation by dialysis membranes: possible role in anaphylactic reaction. J Am Soc Nephrol. 1993 Mar; 3(9):1563-9.
    View in: PubMed
    Score: 0.024
  49. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein. Blood. 1992 Oct 15; 80(8):1980-8.
    View in: PubMed
    Score: 0.023
  50. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma. Blood. 1988 May; 71(5):1334-40.
    View in: PubMed
    Score: 0.017
  51. Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol. 1988; 6:49-83.
    View in: PubMed
    Score: 0.017
  52. The coagulation-kinin pathway of human plasma. Blood. 1987 Jul; 70(1):1-15.
    View in: PubMed
    Score: 0.016
  53. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy. 2005 Apr; 35(4):456-60.
    View in: PubMed
    Score: 0.014
  54. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships. Crit Rev Immunol. 1981 Sep; 3(1):75-93.
    View in: PubMed
    Score: 0.011
  55. The pathogenic basis of urticaria and angioedema: recent advances. Am J Med. 1981 Apr; 70(4):755-8.
    View in: PubMed
    Score: 0.011
  56. Pattern of nasal secretions during experimental influenza virus infection. Rhinology. 1996 Mar; 34(1):2-8.
    View in: PubMed
    Score: 0.007
  57. Activation and control mechanisms of Hageman factor-dependent pathways of coagulation, fibrinolysis, and kinin generation and their contribution to the inflammatory response. J Allergy Clin Immunol. 1975 Dec; 56(6):491-506.
    View in: PubMed
    Score: 0.007
  58. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest. 1975 Dec; 56(6):1650-62.
    View in: PubMed
    Score: 0.007
  59. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol. 1975 Jun; 55(6):394-402.
    View in: PubMed
    Score: 0.007
  60. Mononuclear cell chemotactic activity of kallikrein and plasminogen activator and its inhibition by C1 inhibitor and alpha 2-macroglobulin. J Immunol. 1974 Dec; 113(6):1928-34.
    View in: PubMed
    Score: 0.007
  61. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med. 1972 Jan; 135(1):81-97.
    View in: PubMed
    Score: 0.006
  62. A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. J Exp Med. 1971 Apr 01; 133(4):696-712.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.